PD-1 blockade induces responses by inhibiting adaptive immune resistance

Caroline Robert, Antoni Ribas, Jedd D Wolchok, F Stephen Hodi, Omid Hamid, Richard Kefford, Jeffrey S Weber, Anthony M Joshua, Wen-Jen Hwu, Tara C Gangadhar, Amita Patnaik, Roxana Dronca, Hassane Zarour, Richard W Joseph, Peter Boasberg, Bartosz Chmielowski, Christine Mateus, Michael A Postow, Kevin Gergich, Jeroen Elassaiss-Schaap, Xiaoyun Nicole Li, Robert Iannone, Scot W Ebbinghaus, S Peter Kang, Adil Daud, Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: A randomised dose-comparison cohort of a phase 1 trial The Lancet. ,vol. 384, pp. 1109- 1117 ,(2014) , 10.1016/S0140-6736(14)60958-2

Claire I. Vanpouille-Box, Julie M. Diamond, Jiri Zavadil, James Babb, Dörthe Schaue, Mary Helen Barcellos-Hoff, William H. McBride, Silvia C. Formenti, Sandra Demaria, Abstract 633: Inhibition of TGFβ as a strategy to convert the irradiated tumor into in situ individualized vaccine Cancer Research. ,vol. 74, pp. 633- 633 ,(2014) , 10.1158/1538-7445.AM2014-633

Andrew T Parsa, James S Waldron, Amith Panner, Courtney A Crane, Ian F Parney, Jeffrey J Barry, Kristine E Cachola, Joseph C Murray, Tarik Tihan, Michael C Jensen, Paul S Mischel, David Stokoe, Russell O Pieper, Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma Nature Medicine. ,vol. 13, pp. 84- 88 ,(2007) , 10.1038/NM1517

Harlan S. Robins, Paulo V. Campregher, Santosh K. Srivastava, Abigail Wacher, Cameron J. Turtle, Orsalem Kahsai, Stanley R. Riddell, Edus H. Warren, Christopher S. Carlson, Comprehensive assessment of T-cell receptor β-chain diversity in αβ T cells Blood. ,vol. 114, pp. 4099- 4107 ,(2009) , 10.1182/BLOOD-2009-04-217604

Drew M. Pardoll, The blockade of immune checkpoints in cancer immunotherapy Nature Reviews Cancer. ,vol. 12, pp. 252- 264 ,(2012) , 10.1038/NRC3239

Christopher S. Carlson, Ryan O. Emerson, Anna M. Sherwood, Cindy Desmarais, Moon-Wook Chung, Joseph M. Parsons, Michelle S. Steen, Marissa A. LaMadrid-Herrmannsfeldt, David W. Williamson, Robert J. Livingston, David Wu, Brent L. Wood, Mark J. Rieder, Harlan Robins, Using synthetic templates to design an unbiased multiplex PCR assay Nature Communications. ,vol. 4, pp. 2680- ,(2013) , 10.1038/NCOMMS3680

Mohammad Atefi, Earl Avramis, Amanda Lassen, Deborah J.L. Wong, Lidia Robert, David Foulad, Michael Cerniglia, Bjoern Titz, Thinle Chodon, Thomas G. Graeber, Begonya Comin-Anduix, Antoni Ribas, Effects of MAPK and PI3K Pathways on PD-L1 Expression in Melanoma Clinical Cancer Research. ,vol. 20, pp. 3446- 3457 ,(2014) , 10.1158/1078-0432.CCR-13-2797

Franck Pagès, Anne Berger, Matthieu Camus, Fatima Sanchez-Cabo, Anne Costes, Robert Molidor, Bernhard Mlecnik, Amos Kirilovsky, Malin Nilsson, Diane Damotte, Tchao Meatchi, Patrick Bruneval, Paul-Henri Cugnenc, Zlatko Trajanoski, Wolf-Herman Fridman, Jérôme Galon, Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer The New England Journal of Medicine. ,vol. 353, pp. 2654- 2666 ,(2005) , 10.1056/NEJMOA051424

J. D. Wolchok, A. Hoos, S. O'Day, J. S. Weber, O. Hamid, C. Lebbe, M. Maio, M. Binder, O. Bohnsack, G. Nichol, R. Humphrey, F. S. Hodi, Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria Clinical Cancer Research. ,vol. 15, pp. 7412- 7420 ,(2009) , 10.1158/1078-0432.CCR-09-1624

Julie R. Brahmer, Scott S. Tykodi, Laura Q.M. Chow, Wen-Jen Hwu, Suzanne L. Topalian, Patrick Hwu, Charles G. Drake, Luis H. Camacho, John Kauh, Kunle Odunsi, Henry C. Pitot, Omid Hamid, Shailender Bhatia, Renato Martins, Keith Eaton, Shuming Chen, Theresa M. Salay, Suresh Alaparthy, Joseph F. Grosso, Alan J. Korman, Susan M. Parker, Shruti Agrawal, Stacie M. Goldberg, Drew M. Pardoll, Ashok Gupta, Jon M. Wigginton, Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer The New England Journal of Medicine. ,vol. 366, pp. 2455- 2465 ,(2012) , 10.1056/NEJMOA1200694